Characterization and Mortality Risk of Impaired Left Ventricular Filling in Chronic Obstructive Pulmonary Disease
Mustafa Abdo(Heidelberg University), Benjamin Waschki(University of Lübeck), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Espen E. Groth(German Center for Lung Research), Robert Bals(Ludwig-Maximilians-Universität München), Claus Vogelmeier(German Center for Lung Research), Tobias Welte(Medizinische Hochschule Hannover), Kathrin Kahnert(German Center for Lung Research), Martin Claussen(LungenClinic Grosshansdorf), Franziska Trudzinski(Heidelberg University), Henrik Watz(University of Lübeck), Peter Alter(Philipps University of Marburg), Anne-Marie Kirsten(German Center for Lung Research), Rudolf A. Jörres(German Center for Lung Research)
Cited by 17
Related Papers
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
|American Journal of Respiratory and Critical Care Medicine|2017|3.2k
Clinical and economic burden of community-acquired pneumonia among adults in Europe
|Thorax|2010|1.1k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
|The Lancet Respiratory Medicine|2020|864
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856